novel
influenza
spread
around
world
spring
although
influenza
infect
mild
clinic
cours
pandem
viru
capabl
lead
sever
ill
requir
hospit
exampl
hospit
admiss
rate
children
influenza
twofold
rate
season
influenza
addit
approxim
hospit
patient
admit
icu
patient
die
diseas
caus
death
global
accordingli
increas
need
develop
effect
therapi
treatment
improv
upon
prognosi
sever
case
sever
influenza
infecti
case
cytokin
dysregul
observ
patient
corticosteroid
proven
abl
reduc
system
inflamm
inhibit
prolifer
cytokin
product
previou
metaanalys
patient
acut
long
injuri
acut
respiratori
distress
syndrom
indic
prolong
glucocorticoid
treatment
safe
associ
signific
reduct
marker
system
inflamm
multipl
organ
dysfunct
score
durat
mechan
ventil
icu
length
stay
moreov
nie
colleagu
studi
show
use
corticosteroid
associ
improv
mortal
sever
communityacquir
pneumonia
cap
accord
account
corticosteroid
use
patient
confirm
probabl
viru
infect
variou
dose
regimen
inpati
children
treat
corticosteroid
corticosteroid
empir
use
prefer
lifesav
treatment
observ
sever
patient
includ
acut
respiratori
distress
syndrom
pandem
influenza
although
corticosteroid
wide
use
effect
corticosteroid
pandem
influenza
patient
studi
adequ
thu
still
controversi
exampl
sever
studi
remark
effect
observ
earli
treatment
oseltamivir
steroid
patient
sever
pneumonia
prevent
diseas
progress
addit
number
clinic
case
seri
case
report
shown
patient
sever
respiratori
complic
pneumonia
improv
use
corticosteroid
howev
usa
center
diseas
control
prevent
recommend
use
corticosteroid
primari
medicin
infect
except
reason
dose
indic
specif
reason
exampl
pulmonari
obstruct
septic
shock
moreov
world
health
organ
guidelin
pharmacolog
manag
pandem
influenza
influenza
virus
recommend
system
corticosteroid
administr
patient
sever
progress
clinic
ill
unless
except
circumst
sever
influenza
treatment
guidelin
korea
also
indic
system
corticosteroid
administr
perform
treatment
sever
influenza
patient
unless
therapeut
effect
alreadi
proven
none
guidelin
recommend
systemat
corticosteroid
use
regularli
infect
howev
lack
clinic
evid
make
recommend
guidelin
unconvinc
mani
studi
involv
treatment
sever
case
publish
result
inconsist
could
due
insuffici
sampl
size
complic
clinic
statu
studi
design
knowledg
systemat
literatur
review
evalu
benefit
corticosteroid
sever
infect
princip
resourc
optim
clinic
therapi
influenza
patient
direct
futur
research
warrant
therefor
conduct
present
studi
determin
whether
corticosteroid
treat
sever
infect
clarifi
associ
corticosteroid
mortal
take
account
clinic
statu
studi
design
examin
associ
larger
prospect
cohort
studi
global
set
use
exist
literatur
assess
effect
corticosteroid
treatment
mortal
metaanalysi
conduct
comprehens
literatur
search
englishlanguag
chineselanguag
articl
examin
effect
corticosteroid
treatment
influenza
publish
octob
electron
databas
search
includ
medlin
embas
pubm
cochran
central
regist
control
clinic
trial
univers
saskatchewan
librari
system
china
nation
knowledg
infrastructur
wan
fang
data
cbm
disc
contact
articl
author
inform
clarif
necessari
attempt
made
includ
unpublish
data
search
execut
independ
two
skill
research
search
strategi
consist
term
influenza
viral
pneumon
corticosteroid
steroid
medic
subjecthead
key
word
addit
refer
list
retriev
origin
articl
relev
systemat
review
manual
check
ethic
board
approv
deem
necessari
metaanalysi
previous
publish
studi
random
trial
avail
includ
cohort
studi
studi
includ
cohort
studi
fulfil
follow
select
criteria
enrol
patient
confirm
probabl
suspect
influenza
subject
inpati
admit
icu
critic
ill
corticosteroid
treatment
compar
noncorticosteroid
treatment
within
case
data
hospit
mortal
access
studi
inclus
criteria
enrol
patient
confirm
probabl
suspect
influenza
subject
inpati
admit
icu
critic
ill
death
case
survivor
control
number
patient
receiv
receiv
steroid
treatment
present
two
group
restrict
studi
respect
age
group
studi
exclud
includ
season
influenza
infect
case
vitro
test
anim
experi
case
studi
case
seri
review
letter
articl
target
special
crowd
pregnant
women
patient
hiv
infect
addit
confirm
influenza
case
defin
acut
respiratori
ill
laboratori
confirm
realtim
pcr
viral
cultur
corticosteroid
treatment
defin
system
corticosteroid
use
nonstandard
corticosteroid
use
decid
attend
physician
regardless
type
dosag
frequenc
administr
full
articl
review
select
exclus
public
predefin
inclus
criteria
two
research
independ
also
contact
correspond
author
studi
email
ask
addit
detail
howev
three
author
respond
cohort
studi
follow
inform
collect
studi
first
author
year
public
countri
origin
studi
design
inclusionexclus
criteria
particip
demograph
sampl
size
antivir
treatment
corticosteroid
dose
formul
durat
studi
collect
inform
number
patient
treat
steroid
group
regard
cohort
studi
inform
number
patient
die
group
clinic
outcom
collect
disagr
resolv
consensu
newcastleottawa
scale
score
system
use
assess
methodolog
qualiti
cohort
studi
studi
newcastleottawa
scale
assign
maximum
score
select
compar
exposur
studi
outcom
cohort
studi
henc
score
highest
possibl
reflect
best
qualiti
two
investig
independ
assess
risk
bia
studi
detail
evalu
criteria
shown
addit
file
interrat
agreement
assess
use
cohen
kappa
statist
disagr
resolv
consensu
calcul
rel
risk
death
within
cohort
studi
odd
ratio
use
studi
heterogen
treatment
effect
among
studi
assess
examin
forest
plot
statist
use
cochran
q
statist
signific
heterogen
seen
p
randomeffect
model
select
otherwis
fixedeffect
model
use
twosid
p
consid
statist
signific
signific
heterogen
identifi
subgroup
analys
carri
studi
categor
sampl
size
whether
subject
two
group
compar
term
age
antivir
treatment
whether
studi
includ
probabl
suspect
case
sensit
analysi
exclud
studi
one
one
investig
heterogen
potenti
public
bia
assess
begg
mazumdar
rank
correl
test
observ
funnel
plot
attempt
summar
corticosteroid
effect
clinic
outcom
describ
result
studi
statist
analysi
perform
use
comprehens
metaanalysi
softwar
biostat
inc
englewood
nj
usa
review
manag
softwar
nordic
cochran
center
copenhagen
denmark
sponsor
studi
role
studi
design
data
collect
data
analysi
data
interpret
write
report
decis
submit
paper
public
correspond
author
full
access
data
studi
final
respons
decis
submit
paper
public
refer
screen
studi
includ
final
analysi
figur
fourteen
studi
studi
nine
studi
cohort
studi
total
subject
analyz
subject
studi
subject
cohort
studi
among
studi
seven
studi
conduct
china
three
spain
three
india
two
korea
two
argentina
one
studi
conduct
mexico
turkey
saudi
arabia
franc
finland
remain
studi
multicent
conduct
sever
countri
european
societi
intens
care
medicin
characterist
includ
studi
summar
tabl
particip
studi
inpati
eighteen
studi
includ
patient
icu
critic
ill
case
three
studi
includ
children
one
studi
mention
antivir
treatment
use
patient
corticosteroid
treatment
vari
among
studi
use
methylprednisolon
hydrocortison
dose
vari
mg
daili
howev
still
sever
studi
describ
taper
dose
detail
precis
durat
treatment
two
spanish
studi
show
corticosteroid
administr
standard
decid
attend
physician
without
detail
data
anoth
six
studi
provid
detail
inform
dose
durat
treatment
mode
consensu
review
regard
valid
assess
cohen
kappa
overal
qualiti
includ
studi
moder
analys
present
figur
figur
studi
retrospect
observ
studi
common
bia
lack
compar
term
age
antivir
therapi
studi
group
addit
studi
provid
detail
data
regard
corticosteroid
use
studi
data
obtain
either
registr
system
review
hospit
record
respons
rate
report
therefor
judg
high
risk
respect
studi
demonstr
exclud
steroidus
case
underlin
diseas
studi
mention
signific
heterogen
found
studi
randomeffect
model
therefor
use
combin
ci
figur
subgroup
analysi
conduct
investig
heterogen
result
shown
addit
file
plot
show
sampl
size
studi
well
compar
term
age
antivir
treatment
significantli
influenc
final
mortal
outcom
heterogen
statist
signific
studi
categor
accord
whether
enrol
suspect
probabl
case
pool
ci
studi
enrol
confirm
case
pool
statist
signific
group
ci
sensit
analysi
found
heterogen
examin
exclud
rio
colleagu
studi
result
suggest
high
mortal
associ
steroid
treatment
ci
regard
nine
cohort
studi
note
signific
heterogen
studi
fixedeffect
model
use
nine
cohort
studi
rel
risk
ci
suggest
mortal
higher
patient
given
steroid
figur
subgroup
analys
shown
addit
file
reveal
rel
risk
higher
studi
poor
qualiti
good
qualiti
studi
howev
differ
statist
signific
besid
inclus
probabl
suspect
case
significantli
chang
result
consist
show
steroid
treatment
risk
factor
mortal
zhang
colleagu
studi
show
corticosteroid
treatment
better
therapeut
effect
compar
nonsteroid
treatment
similarli
anoth
chines
studi
indic
patient
steroid
treatment
group
shorter
durat
fever
shorter
durat
inflamm
addit
martinloech
colleagu
studi
show
patient
receiv
earli
corticosteroid
therapi
hospitalacquir
pneumonia
frequent
patient
regard
length
hospit
kudo
colleagu
studi
demonstr
increas
length
hospit
stay
patient
corticosteroid
treatment
compar
control
despit
signific
differ
found
also
linko
colleagu
studi
show
length
icu
hospit
stay
significantli
longer
patient
treat
corticosteroid
regard
durat
mechan
ventil
diaz
colleagu
display
differ
corticosteroid
noncorticosteroid
group
contrast
linko
colleagu
studi
show
patient
treat
corticosteroid
significantli
longer
durat
mechan
ventil
sinc
mean
differ
provid
linko
colleagu
studi
abl
calcul
pool
effect
viasu
colleagu
studi
found
patient
receiv
corticosteroid
treatment
need
significantli
time
reach
clinic
stabil
present
metaanalysi
public
bia
observ
studi
cohort
studi
use
begg
mazumdar
rank
correct
test
p
p
howev
funnel
plot
provid
evid
public
bia
type
studi
addit
file
influenza
pandem
debat
whether
use
corticosteroid
treatment
sever
influenza
patient
resurfac
disput
clinician
accord
review
corticosteroid
administr
like
increas
mortal
patient
influenza
trend
consist
regardless
qualiti
well
sampl
size
studi
apart
studi
includ
metaanalysi
mani
studi
refer
steroid
use
outcom
report
corticosteroid
neg
effect
effect
treatment
exampl
balaganesakumar
colleagu
found
corticosteroid
treatment
would
caus
higher
risk
poor
patient
outcom
report
show
patient
receiv
corticosteroid
like
develop
secondari
bacteri
pneumonia
associ
increas
risk
develop
critic
ill
icu
admiss
prolong
icu
stay
possibl
explan
neg
effect
corticosteroid
might
corticosteroid
could
inhibit
immun
reaction
howev
immun
system
activ
order
elimin
viru
alter
immun
reaction
thu
might
lead
prolong
viru
viremia
delay
viral
clearanc
ultim
increas
risk
mortal
inde
sever
studi
reveal
posit
role
corticosteroid
use
anim
model
case
seri
lack
control
group
therefor
might
difficult
draw
conclus
corticosteroid
advantag
nonus
corticosteroid
besid
although
previou
studi
suggest
clinic
outcom
patient
hospit
cap
improv
system
corticosteroid
research
point
studi
includ
predominantli
cap
case
bacteri
infect
given
appropri
antibiot
therapi
thu
encourag
result
popular
cap
especi
viral
infect
nevertheless
studi
limit
firstli
heterogen
ignor
research
sinc
imposs
conduct
clinic
trial
critic
ill
patient
observ
studi
retriev
enrol
metaanalysi
observ
studi
potenti
suscept
bia
induc
betweenstudi
heterogen
due
clinic
divers
draw
robust
conclus
second
notic
clinician
critic
patient
like
given
steroid
patient
mild
case
sever
ill
therefor
taken
account
among
includ
research
paper
studi
conduct
multivari
analysi
adjust
potenti
confound
factor
determin
whether
corticosteroid
treatment
predictor
mortal
among
studi
show
corticosteroid
treatment
independ
risk
factor
mortal
although
trend
toward
greater
mortal
remain
three
studi
suggest
corticosteroid
treatment
could
increas
mortal
risk
independ
realiti
abovement
factor
draw
solid
conclus
effect
corticosteroid
treat
sever
influenza
case
besid
difficult
evalu
fairli
effect
accord
dose
time
given
baselin
steroid
use
steroid
usag
vari
attend
physician
studi
gave
detail
inform
henc
clinic
studi
especi
compar
rigor
design
regard
time
formul
corticosteroid
dosag
durat
length
taper
well
random
studi
may
help
clarifi
issu
find
suggest
corticosteroid
benefici
effect
treat
patient
influenza
result
provid
evid
regard
therapeut
strategi
world
health
organ
usa
center
diseas
control
prevent
guidelin
stronger
studi
design
data
replic
necessari
move
forward
find
suggest
corticosteroid
benefici
effect
treat
patient
influenza
avail
evid
support
use
corticosteroid
standard
care
patient
sever
influenzaour
paper
interest
medic
research
physician
fight
influenza
first
line
